Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Steece-Collier

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Neurobiology of Disease|November 14, 2020
The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in ratsNatosha M Mercado, Jennifer A Stancati, Caryl E Sortwell, et al.
Experimental Neurology|May 11, 2020
Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian ratsKathy Steece-Collier, Timothy J Collier, Jack W Lipton, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Complement Dysregulation During the Early Phases of SynucleinopathyHina Khan, Mary Gifford, Arash Kordbacheh, et al.
Scientific Reports|November 29, 2017
Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein OverexpressionD Luke Fischer, Fredric P Manfredsson, Christopher J Kemp, et al.
Journal of Parkinson'S Disease|February 14, 2012
Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortexAnne L Spieles-Engemann, Kathy Steece-Collier, Michael M Behbehani, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2015
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's DiseaseChristopher B Divito, Kathy Steece-Collier, Daniel T Case, et al.
Plos One|May 1, 2023
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primatesDanish M Anwer, Francesco Gubinelli, Yunus A Kurt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2011
Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine modelSara E Gombash, Jack W Lipton, Timothy J Collier, et al.
Experimental Neurology|July 28, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesiaMitchell J Bartlett, Andrew J Flores, Tony Ye, et al.
Neurobiology of Disease|June 21, 2015
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degenerationKatrina L Paumier, Kelvin C Luk, Fredric P Manfredsson, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Neurobiology of Disease|November 14, 2020
The BDNF Val66Met polymorphism (rs6265) enhances dopamine neuron graft efficacy and side-effect liability in rs6265 knock-in ratsNatosha M Mercado, Jennifer A Stancati, Caryl E Sortwell, et al.
Experimental Neurology|May 11, 2020
Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian ratsKathy Steece-Collier, Timothy J Collier, Jack W Lipton, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2026
Complement Dysregulation During the Early Phases of SynucleinopathyHina Khan, Mary Gifford, Arash Kordbacheh, et al.
Scientific Reports|November 29, 2017
Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein OverexpressionD Luke Fischer, Fredric P Manfredsson, Christopher J Kemp, et al.
Journal of Parkinson'S Disease|February 14, 2012
Subthalamic nucleus stimulation increases brain derived neurotrophic factor in the nigrostriatal system and primary motor cortexAnne L Spieles-Engemann, Kathy Steece-Collier, Michael M Behbehani, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 13, 2015
Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's DiseaseChristopher B Divito, Kathy Steece-Collier, Daniel T Case, et al.
Plos One|May 1, 2023
A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primatesDanish M Anwer, Francesco Gubinelli, Yunus A Kurt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2011
Striatal pleiotrophin overexpression provides functional and morphological neuroprotection in the 6-hydroxydopamine modelSara E Gombash, Jack W Lipton, Timothy J Collier, et al.
Experimental Neurology|July 28, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesiaMitchell J Bartlett, Andrew J Flores, Tony Ye, et al.
Neurobiology of Disease|June 21, 2015
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degenerationKatrina L Paumier, Kelvin C Luk, Fredric P Manfredsson, et al.
Pageof 6